ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

LYRA Lyra Therapeutics Inc

5.16
0.43 (9.09%)
Fuera de horario
Última actualización: 16:46:23
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Lyra Therapeutics Inc LYRA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.43 9.09% 5.16 16:46:23
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.73 4.68 5.20 5.16 4.73
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:04GLOBELyra Therapeutics Reports First Quarter 2024 Financial..
26/4/202415:51GLOBELyra Therapeutics Announces Inducement Grants Under Nasdaq..
21/3/202415:01GLOBELyra Therapeutics Reports Fourth Quarter and Full Year 2023..
01/3/202415:01GLOBELyra Therapeutics Announces Inducement Grant Under Nasdaq..
15/2/202408:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202419:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202417:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:34EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202405:13EDGAR2Form 8-K - Current report
28/12/202305:40EDGAR2Form 8-K - Current report
18/12/202315:16EDGAR2Form 8-K - Current report
16/11/202316:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/11/202316:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:09EDGAR2Form 8-K - Current report
07/11/202315:01GLOBELyra Therapeutics Reports Third Quarter 2023 Financial..
07/11/202306:00GLOBELyra Therapeutics to Participate in Upcoming Investor..
16/10/202306:00GLOBELyra Therapeutics Announces Appointment of Ronan O’Brien as..
12/9/202315:01EDGAR2Form 8-K - Current report
12/9/202306:00GLOBELyra Therapeutics Announces Positive Topline Results from..
06/9/202307:00GLOBELyra Therapeutics to Participate in Upcoming Investor..
01/9/202315:03EDGAR2Form 8-K - Current report
01/9/202315:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/8/202306:00GLOBELyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I..
25/8/202315:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/8/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202315:03EDGAR2Form 8-K - Current report
08/8/202315:01GLOBELyra Therapeutics Reports Second Quarter 2023 Financial..
14/7/202315:06EDGAR2Form 8-K - Current report
13/7/202306:30GLOBELyra Therapeutics to Present at William Blair Virtual..
12/7/202317:36EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
07/7/202315:44EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/7/202320:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202320:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202320:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202315:06EDGAR2Form S-3 - Registration statement under Securities Act of..
02/6/202315:01GLOBELyra Therapeutics Announces Inducement Grant Under Nasdaq..
02/6/202306:30GLOBELyra Therapeutics to Present at Jefferies Healthcare..
01/6/202306:29GLOBELyra Therapeutics Announces Closing of $50.0 Million Private..
26/5/202306:57GLOBELyra Therapeutics Announces $50.0 Million Private Placement
12/5/202306:00GLOBELyra Therapeutics Reports First Quarter 2023 Financial..
09/5/202315:01GLOBELyra Therapeutics to Present at Bank of America Securities..

Su Consulta Reciente

Delayed Upgrade Clock